Genelux GNLX
NASDAQ GNLX
$1.98 -0.09 (-4.35%)
At close: Oct 22, 2026 · 4:00 PM EDT

Genelux (GNLX) Revenue (2022 - 2024)

Updated

Genelux's Revenue was $8,000 in FY2025, unchanged from $8,000 in FY2024.

Analysis

Genelux (GNLX) Revenue (2022 - 2024) Analysis & Trends

From FY2022 onward, Genelux has reported Revenue for 4 years.

  • Revenue shows a three-year compound annual growth rate of -91.0% (FY2022 to FY2025).
  • Annual Revenue has moved between $8,000 (FY2024) and $11.07 million (FY2022) over five years.
  • Per Business Quant data, Revenue in earlier years was $8,000 in FY2024 (-95.3%), $170,000 in FY2023 (-98.5%) and $11.07 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 25.40 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 16.99 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 15.38 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 7.80 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 15.03 Bn
10 Genelux 88.78 Mn 27.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 8,000.00
Mar 31, 2023 170,000.00
Dec 31, 2022 68,000.00
Sep 30, 2022 11.00 Mn
API Access

Genelux Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=GNLX&period=max&api_key=YOUR_API_KEY